Autonomix Medical, Inc. (NASDAQ:AMIX) Sees Large Drop in Short Interest

Autonomix Medical, Inc. (NASDAQ:AMIX) was the target of a significant drop in short interest in the month of October. As of October 15th, there was short interest totalling 136,100 shares, a drop of 23.7% from the September 30th total of 178,400 shares. Approximately 1.1% of the company’s stock are short sold. Based on an average daily volume of 420,800 shares, the days-to-cover ratio is currently 0.3 days.

Wall Street Analysts Forecast Growth

Separately, LADENBURG THALM/SH SH assumed coverage on shares of Autonomix Medical in a report on Tuesday, September 3rd. They set a “buy” rating and a $1.40 price objective for the company.

Autonomix Medical Trading Down 22.1 %

AMIX stock traded down $2.19 during mid-day trading on Friday, hitting $7.71. The company had a trading volume of 137,513 shares, compared to its average volume of 84,444. The company has a debt-to-equity ratio of 0.20, a quick ratio of 9.27 and a current ratio of 9.27. Autonomix Medical has a 12 month low of $7.51 and a 12 month high of $152.00. The stock’s fifty day moving average price is $0.79 and its two-hundred day moving average price is $1.42.

Autonomix Medical (NASDAQ:AMIX) last announced its quarterly earnings data on Tuesday, August 13th. The company reported ($0.14) EPS for the quarter. Equities analysts forecast that Autonomix Medical will post -0.5 earnings per share for the current year.

Autonomix Medical Company Profile

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals.